Exclusion Criteria:~* Patients with an Axis I (DSM IV) diagnosis of:~ * delirium~ * amnestic disorders~ *
bipolar disorder~ * schizophrenia or schizoaffective disorder~ * mood disorder with psychotic features~*
Patients with reversible causes of dementia~* Patients with psychotic symptoms continuously present since prior
to the onset of the symptoms of dementia~* Patients with psychotic symptoms that are better accounted for by
another general medical condition or by direct physiological effects of a substance~* Patients with a current
major depressive episode with psychotic symptoms of hallucinations or delusions~* Patients with a diagnosis of
dementia related to infection with the human immunodeficiency virus~* Patients with substance-induced
persistent dementia~* Patients with dementia due to vascular causes, multi-infarct, head trauma, Pick's
disease, Parkinson's disease, frontal or temporal dementia, Lewy body dementia, or any specific non-Alzheimer's
type dementia~* Patients with seizure disorders~* Patients who have been refractory to neuroleptics used to
treat psychotic symptoms in the past when treated for an adequate period with a therapeutic dose, unless
permission is obtained from Bristol-Myers Squibb~* Patients who have met DSM-IV criteria for any significant
substance use disorder within the 6 months prior to the start of screening
